chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.  Concomitant medication was not provided.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No Treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: My symptoms from booster; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (My symptoms from booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (My symptoms from booster). At the time of the report, VACCINATION COMPLICATION (My symptoms from booster) outcome was unknown.            No concomitant medication details was provided. No treatment medication details was provided.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.  The pharmacist reported about the administration of expired moderna vaccine that was given as booster shot to patient. The vaccines was stored in freezer, which was taken out one to two vials and place in fridge each day as needed.
Age: 35.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported  No Treatment medication reported   The vaccines was  stored in freezer,  out one to two vials were taken out and placed in fridge each day as needed. Around 500 patients received the vaccine.
Age: 41.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitants medications was reported.   No treatments medications was reported.  Patient name Bascom Branbdon, phone number 8018304343, Rx Number 804147.
Age: 61.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.  The vaccine was stored in freezer and taken out one or two vials and placed in fridge each day as needed.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Feeling abnormal, Gait disturbance, Headache
Clinical narrative: Hurting so bad/She was hurting; Feels like hell; Really sick/She feels sick; I was up all night/She was up all; Can barely walk; Aches and pains in her bones all over; Slight fever/running a temperature of 99.5; Headache off and on; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Hurting so bad/She was hurting), FEELING ABNORMAL (Feels like hell), ILLNESS (Really sick/She feels sick), INSOMNIA (I was up all night/She was up all) and GAIT DISTURBANCE (Can barely walk) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013H21B and 030H21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Back surgery and Surgery (Shoulder surgery). Concurrent medical conditions included Depression and Pain (Pain management for knee replacement).   On 05-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Hurting so bad/She was hurting), FEELING ABNORMAL (Feels like hell), ILLNESS (Really sick/She feels sick), INSOMNIA (I was up all night/She was up all), GAIT DISTURBANCE (Can barely walk), BONE PAIN (Aches and pains in her bones all over), PYREXIA (Slight fever/running a temperature of 99.5) and HEADACHE (Headache off and on). At the time of the report, PAIN (Hurting so bad/She was hurting) and HEADACHE (Headache off and on) had not resolved and FEELING ABNORMAL (Feels like hell), ILLNESS (Really sick/She feels sick), INSOMNIA (I was up all night/She was up all), GAIT DISTURBANCE (Can barely walk), BONE PAIN (Aches and pains in her bones all over) and PYREXIA (Slight fever/running a temperature of 99.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, Body temperature: 99.5 A temperature of 99.5 Fahrenheit..         Concomitant medications included pain medications for pain management for knee replacement.  Patient started to experience events on an unknown date in Feb 2022.  No Treatment medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Insomnia, Pain, Pyrexia
Clinical narrative: Hurting so bad/She was hurting; Feels like hell; Really sick/She feels sick; I was up all night/She was up all; Can barely walk; Aches and pains in her bones all over; Slight fever/running a temperature of 99.5; Headache off and on; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Hurting so bad/She was hurting), FEELING ABNORMAL (Feels like hell), ILLNESS (Really sick/She feels sick), INSOMNIA (I was up all night/She was up all) and GAIT DISTURBANCE (Can barely walk) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013H21B and 030H21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Back surgery and Surgery (Shoulder surgery). Concurrent medical conditions included Depression and Pain (Pain management for knee replacement).   On 05-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Hurting so bad/She was hurting), FEELING ABNORMAL (Feels like hell), ILLNESS (Really sick/She feels sick), INSOMNIA (I was up all night/She was up all), GAIT DISTURBANCE (Can barely walk), BONE PAIN (Aches and pains in her bones all over), PYREXIA (Slight fever/running a temperature of 99.5) and HEADACHE (Headache off and on). At the time of the report, PAIN (Hurting so bad/She was hurting) and HEADACHE (Headache off and on) had not resolved and FEELING ABNORMAL (Feels like hell), ILLNESS (Really sick/She feels sick), INSOMNIA (I was up all night/She was up all), GAIT DISTURBANCE (Can barely walk), BONE PAIN (Aches and pains in her bones all over) and PYREXIA (Slight fever/running a temperature of 99.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, Body temperature: 99.5 A temperature of 99.5 Fahrenheit..         Concomitant medications included pain medications for pain management for knee replacement.  Patient started to experience events on an unknown date in Feb 2022.  No Treatment medications were reported.
Age: 77.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No treatment medications were reported.  Reporter stated that they have administered expired Moderna COVID-19 vaccine that were given as booster shot to the patient. It was reported that the vaccine was stored in freezer and they took out one to two vials and placed in fridge each day as needed.
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. Rx Number was  The Patient received booster shot of Moderna COVID-19 vaccine
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment given to patients.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 01-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the vaccines were stored in freezer and required vials were taken out to place in fridge as needed.  No concomitant medications were reported. No treatment medications were reported.
Age: 51.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  It was reported that the vaccine was stored in the freezer and they would take out one to two vials and keep in the fridge as needed each day.  It was reported that no treatment was provided to the patients.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received first dose on 26-Mar-2021, second dose on 09-Apr-2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 26-Mar-2021, second dose on 09-Apr-2021) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 002C21A) for COVID-19 vaccination.     Concurrent medical conditions included ADHD, Anxiety, Developmental delay and Hypotension. Concomitant products included ESCITALOPRAM and TRAZODONE for Anxiety, PRAZOSIN for Nightmares.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 09-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 26-Mar-2021, second dose on 09-Apr-2021). On 09-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 26-Mar-2021, second dose on 09-Apr-2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported. Patient had PTD. Patient had PTSA related nightmares for which she takes Prazosin.   This case was linked to MOD-2022-472187 (Patient Link).
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medication was reported. No concomitant medication was reported.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.   No Medical History information was reported.   On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  No treatment information was provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sick; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (Sick) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.      Concurrent medical conditions included Multiple sclerosis, Cough, Ache NOS, Chills, Headache and Fever.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced ILLNESS (Sick). At the time of the report, ILLNESS (Sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product information was provided No treatment medication information was provided.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired Moderna vaccine) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired Moderna vaccine). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired Moderna vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Rx number reported as 801994.  It was reported that the vaccine was stored in freezer, one of two vials were taken out and placed in fridge each day as needed.  No treatment given to the patient.
Age: 82.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fat tissue decreased, Hair colour changes, Therapeutic response unexpected, Waist circumference
Clinical narrative: Her face, and body started changing and she looked younger; Her waist thinned out and she had less fat on her; 1 month after the first shot, her hair started coming in black at the roots instead of gray; This spontaneous case was reported by a consumer and describes the occurrence of HAIR COLOUR CHANGES (1 month after the first shot, her hair started coming in black at the roots instead of gray), THERAPEUTIC RESPONSE UNEXPECTED (Her face, and body started changing and she looked younger) and FAT TISSUE DECREASED (Her waist thinned out and she had less fat on her) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (6 months prior to the 1st dose of Moderna vaccine patient was hospitalized with COVID-19).    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In July 2021, the patient experienced HAIR COLOUR CHANGES (1 month after the first shot, her hair started coming in black at the roots instead of gray). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Her face, and body started changing and she looked younger) and FAT TISSUE DECREASED (Her waist thinned out and she had less fat on her). At the time of the report, HAIR COLOUR CHANGES (1 month after the first shot, her hair started coming in black at the roots instead of gray), THERAPEUTIC RESPONSE UNEXPECTED (Her face, and body started changing and she looked younger) and FAT TISSUE DECREASED (Her waist thinned out and she had less fat on her) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Waist circumference: decreased Waist thinned out.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant use were reported. No Treatment were reported. Patient thought she was imagining things, and it started to wear off before the second dose, like they said the immunity does. Patient reported that has not had plastic surgery.   This case was linked to MOD-2022-473698 (Patient Link).
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.  The Pharmacist reported administration of an expired  Moderna vaccine to patients of around 490 to 500 people on the date last Oct 20,2021 to Nov 29,2021.  Reporter has provided lot Number of vaccine as follows: 006C21A (10-10-2021), 026B21A (09-17-2021), and 031B21A (9-22-2021).  Reporter stated that vaccines were stored in freezer and used one to two vials which were placed in fridge each day as needed.
Age: 20.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administration of expired Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) in a 20-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   No treatment was given to the patient.   The vaccines were stored in freezer, were taken out one to two vials and placed in fridge each day as needed.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Received expired dose; Patients were administered a dose from a vial that was punctured and left at RT for 5 days.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose) and PRODUCT STORAGE ERROR (Patients were administered a dose from a vial that was punctured and left at RT for 5 days.) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069F21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Dose 1, Batch number: EL9264) on 03-Feb-2021, Pfizer (Dose 2 and Batch number: EN6201) on 24-Feb-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 01-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milligram. On 01-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose) and PRODUCT STORAGE ERROR (Patients were administered a dose from a vial that was punctured and left at RT for 5 days.). On 01-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Received expired dose) and PRODUCT STORAGE ERROR (Patients were administered a dose from a vial that was punctured and left at RT for 5 days.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No any concomitant medications were reported. No any treatment medications were reported.  Patient experienced No adverse event after taking the vaccine. Patient received the dose in the deltoid muscle. The vial did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2022: Follow-up received: Patient demographics-race, ethnicity updated, Suspect drug details-route, body site and dosage regimen updated, Narrative updated: No adverse event occurred.
Age: 44.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant  medication were reported.   No treatment drug were reported.  The vaccines was stored in freezer, they take out one to two vials and place in fridge each day as needed.
Age: 39.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.  The Pharmacist reported administration of an expired  Moderna vaccine to patients of around 490 to 500 people on the date last Oct 20,2021 to Nov 29,2021.  Reporter has provided lot Number of vaccine as follows: 006C21A (10 Oct 2021), 026B21A (17 Sep 2021), and 031B21A (22 Sep 2021).  Reporter stated that vaccines were stored in freezer and used one to two vials which were placed in fridge each day as needed.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: inadvertently expired dose was administered; a vial that was punctured and left at room temperature for 5 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (inadvertently expired dose was administered) and PRODUCT STORAGE ERROR (a vial that was punctured and left at room temperature for 5 days) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 048A21A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022 at 5:15 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 01-Feb-2022 at 5:15 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (inadvertently expired dose was administered) and PRODUCT STORAGE ERROR (a vial that was punctured and left at room temperature for 5 days). On 01-Feb-2022 at 5:15 PM, EXPIRED PRODUCT ADMINISTERED (inadvertently expired dose was administered) and PRODUCT STORAGE ERROR (a vial that was punctured and left at room temperature for 5 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient had no acute illness at the time of vaccination and up to one month before.  The vial was initially stored in the refrigerator at 27-Jan-2022. It was reported that, a vial was punctured on 27-Jan-2022 at 08:30 AM and left at room temperature for 5 days and was used in a vaccination on 01-Feb-2022 at 17:15. The vial did not undergo any temperature excursions. The vaccine was administered in deltoid muscle (unspecified). The patient did not experience any adverse event.  No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2022: Follow up information included patient's race, suspect vaccine dose information and narrative updated.
Age: 26.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant  and treatment were reported.     On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant  and treatment were reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Product administered at inappropriate site, Pyrexia
Clinical narrative: Felt like he had a fever/temperature was 100.2 F, 100.0 F; second dose like 4 inches lower on my arm than the last dose; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Felt like he had a fever/temperature was 100.2 F, 100.0 F) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (second dose like 4 inches lower on my arm than the last dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045L21A) for COVID-19 vaccination.     The patient's past medical history included Headache and Pain neck. Concurrent medical conditions included Sinusitis.    On 03-Feb-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022, the patient experienced PYREXIA (Felt like he had a fever/temperature was 100.2 F, 100.0 F) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (second dose like 4 inches lower on my arm than the last dose). On 03-Feb-2022, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (second dose like 4 inches lower on my arm than the last dose) had resolved. At the time of the report, PYREXIA (Felt like he had a fever/temperature was 100.2 F, 100.0 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) 100.2 F and 100.0 (High) 100.0 F.         The patient reported that second dose was closer to his bicep. No concomitant product information  was provided. No treatment medication information  was provided.   This case was linked to MOD-2022-473681 (Patient Link).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Received expired dose; vial that was punctured and left at room temperature for 5 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose) and PRODUCT STORAGE ERROR (vial that was punctured and left at room temperature for 5 days) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 031B21A and 048A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022 at 5:15 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 27-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (vial that was punctured and left at room temperature for 5 days). On 01-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose). On 01-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Received expired dose) had resolved. At the time of the report, PRODUCT STORAGE ERROR (vial that was punctured and left at room temperature for 5 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment information was reported.  Vaccination location reported as deltoid.  It was reported that inadvertently expired doses were administered to 8 patients. The vial was initially stored in the refrigerator on 27-Jan-2022. The vial was first punctured on 27-Jan-2022, 8.30am. On 01-Feb-2022 at 2.30pm-4.30pm, the vaccine was administered. The vial was stored post puncture in RT. The vial did not undergo any temperature excursions. It was reported that no adverse event occurred.    Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2022: Significant Follow up, patient demographics and narrative updated.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: received expired dose; Patients were administered a dose from a vial that was punctured and left at RT for 5 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired dose) and PRODUCT STORAGE ERROR (Patients were administered a dose from a vial that was punctured and left at RT for 5 days) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 030A21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022 at 5:15 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 01-Feb-2022 at 5:15 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired dose) and PRODUCT STORAGE ERROR (Patients were administered a dose from a vial that was punctured and left at RT for 5 days). On 01-Feb-2022 at 5:15 PM, EXPIRED PRODUCT ADMINISTERED (received expired dose) and PRODUCT STORAGE ERROR (Patients were administered a dose from a vial that was punctured and left at RT for 5 days) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Patient received booster dose on deltoid.  Date the vial was initially stored in the refrigerator- 27-Jan-2022. Vial was first punctured on 27-Jan-2022 at 8.30 AM. Vial stored post puncture at room temperature and didn't undergone any temperature excursions. It was reported that the patient did not experienced any adverse event.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2022: Updated patient demographics, suspect details (dose time) and narrative.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: administered a dose from a vial that was punctured and left at RT for 5 days; vial that was punctured and left at RT for 5 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered a dose from a vial that was punctured and left at RT for 5 days) and PRODUCT STORAGE ERROR (vial that was punctured and left at RT for 5 days) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A and 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022 at 5:15 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 27-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (vial that was punctured and left at RT for 5 days). On 01-Feb-2022 at 5:15 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered a dose from a vial that was punctured and left at RT for 5 days). On 01-Feb-2022, PRODUCT STORAGE ERROR (vial that was punctured and left at RT for 5 days) had resolved. On 01-Feb-2022 at 5:15 PM, EXPIRED PRODUCT ADMINISTERED (administered a dose from a vial that was punctured and left at RT for 5 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. Date the vial was initially stored in the refrigerator- 27Jan22 Date(s) and time(S) vial was first punctured: 27Jan22 at 8.30am. Date(s) and time(s) of administration of vaccine: 01Feb22 between 2.30pm-4.30pm vial stored post puncture at room temperature. vial didn't undergone  any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2022: Follow-up received contains Significant information-Patient demographics- updated, Suspect drug details-route, body site and dosage regimen updated, Narrative updated: No adverse event occurred.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received expired dose/Patients were administered a dose from a vial that was punctured and left at RT for 5 days.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired dose/Patients were administered a dose from a vial that was punctured and left at RT for 5 days.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 016M20A and 002B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022 at 5:15 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 01-Feb-2022 at 5:15 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired dose/Patients were administered a dose from a vial that was punctured and left at RT for 5 days.). On 01-Feb-2022, EXPIRED PRODUCT ADMINISTERED (received expired dose/Patients were administered a dose from a vial that was punctured and left at RT for 5 days.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took 3rd dose of Vaccine IM- Deltoid   Concomitant medication information was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2022: Follow up received on 04-FEB-2022 : Contains Significant information - Updated Patient ethnicity, Added Suspect drug information Dose 1, Dose 2 and Dose 3,  Added Vaccine facility information, Updated event description, Updated  i-narrative